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THE ESDAP DIPLOMA IN 
PSYCHODERMATOLOGY
Francoise Poot1, Francesca Sampogna2, Uwe Gieler3, Lucia To-
mas-Aragones4
1Dermatology Department, ULB, Brussels, Belgium, 2Clinical Epi-
demiology Unit, IDI-IRCCS, Rome, Italy, 3Department of Derma-
tology, Justus Liebig University, Giessen, Germany, 4Department 
of Psychology, University of Zaragoza, Zaragoza, Spain
Psychodermatological consultations are a reality in most Eu-
ropean countries nowadays. It is therefore important for health 
providers to be properly trained to deal with dermatological 
patients who present with specific needs. Throughout Europe, 
psychotherapy is being regulated and protected by law and the 
idea is for this diploma in Psychodermatology to be adapted to 
current regulations. ESDaP will offer these training courses on 
an international basis. Each teaching module offered will be the 
same in different European countries, and offered in different 
languages by a team of experts coordinated by an ESDaP EC 
member. The training program will consist of 3 levels. The levels 
and topics covered are as follows: Level 1: psychodermatologist, 
skin–psychologist, skin–psychiatrist. Acquiring competences in: 
doctor–patient relationship and communication skills, alexithymia, 
anxiety, depression, self-inflicted skin lesions, body dysmorphic 
disorders, delusion of parasitosis and other delusions, quality of 
life, psychopharmacological treatment, and psychological inter-
ventions. Level 2: Psychotherapeutic level A. Counsellor: first 
level dermatologist/psychologist/ psychiatrist trained as counsel-
lor in various approaches (Habit reversal, atopy school, etc.) B. 
Practitioner: the same candidates reaching the requirements for 
the European Certificate in Psychotherapy Additionally, ESDaP 
will acknowledge and certify a multidisciplinary consultation der-
matologist–psychologist/psychiatrist when one of the consultants 
reaches Level 2.
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DEVELOPMENT AND EVALUATION OF 
THE PSOWELL™ APPROACH FOR THE 
MANAGEMENT OF PEOPLE WITH COMPLEX 
PSORIASIS
Rachael Hewitt, Christine Bundy
Cardiff University, Wales, UK
Psoriasis, a long-term immune-mediated inflammatory skin 
disease, affects 2–3% of the UK population; around a third of 
patients develop associated joint disease (psoriatic arthritis). These 
conditions are associated with increased cardiovascular disease 
(CVD) risk, greater prevalence of modifiable CVD risk factors 
that include smoking, excessive alcohol consumption, obesity, 
physical inactivity and associated distress. Interventions should 
address the psychological and lifestyle factors that precipitate 
these associated comorbid conditions and CVD risk, focusing 
on behaviour change. Psoriasis disease requires effective health 
behaviour change, yet clinicians feel unprepared to facilitate this. 
PsoWell™ (Psoriasis and Wellbeing), a novel training programme, 
that incorporates Motivational Interviewing, improves clinicians’ 
knowledge and skills to manage psoriasis and is acceptable and 
feasible to incorporate into clinical consultations. We report on a 
mixed-methods implementation study to: 1) Establish PsoWel™ 
clinics within dermatology services across the UK. 2) Investigate 
whether the PsoWell™ training improves clinicians’ consultation 
skills, knowledge of psoriatic diseases, comorbidities and risk 
factors. 3) Determine whether the PsoWell™ training programme 
is feasible and acceptable to dermatology specialists and psycho-
logists. 4) Explore whether the PsoWell™ consultation style is 
acceptable to patients. 5) Develop the evidence base for PsoWell 
clinics as part of dermatology service provision.
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SURVEYING DERMATOLOGISTS IN THE 
MIDDLE EAST FOR THE PRACTICE 
PSYCHODERMATOLOLGY
Ossama Osman1, Mohammad Jafferany2
1College of Medicine and Health Sciences, United Arab Emirates 
University, 2Psychiatry and Behavioral Sciences, College of Medi-
cine, Central Michigan University, CMU HealthCare East Cam-
pus Saginaw, MI
Background: Many dermatologic patients suffer from comorbid 
psychiatric symptoms. Proper treatment of these patients require 
parallel psychiatric care. The main objective of this study was 
to assess awareness of Middle East dermatologists to psycho-
cutaneous medicine. Methods: we utilized a survey originally 
developed for dermatologists in the U.S. to assess regional expe-
rience with psychodermatologic disorders. Results: Fifty-seven 
dermatologists from 7 countries (United Arab Emirates, Saudi 
Arabia, Egypt, Kuwait, Iraq, Jordan and Lebanon) completed 
the survey. Forty-nine (86%) reported clear understanding of 
the term psychodermatology, 9 (16%) were very comfortable 
in diagnosing and treating these disorders, and 52 (91%) were 
unaware of patient/family professional electronic resources on 
psychodermatology. Acne, alopecia, vitiligo, atopic dermatitis, 
and psoriasis were common skin diagnoses coupled with psy-
chiatric manifestations. Thirteen (23%) dermatologists expressed 
interest in attending educational activities on managing psy-
chodermatologic diseases. Conclusion: Managing patients with 
psychocutaneous disorders required more sufficient experience. 
This survey supports need for incorporating formal training on 
psychodermatology in postgraduate dermatology programs. 
There is also a need for establishing dermatology–psychiatry 
liaisons, especially acquainted with managing these patients. 
Reference: Osman OT, et al. Attentiveness of dermatologists in the 
Middle East to psychocutaneous medicine. Prim Care Companion CNS 
Disord 2017; 19(2):16.
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THE TREATMENT OF DELUSIONALITY
Yak Mee Wong1, Patrick Kemperman2, Dorien Nieman1, Nienke 
Vulink1
1Department of Psychiatry, 2Department of Dermatology, Amster-
dam University Medical Centers, Location AMC, Amsterdam, The 
Netherlands
Delusionality is a key element in certain psychiatric disorders. 
Multiple factors are involved in the generation of delusionality. 
Selective attention is the most investigated possible contributor of 
delusionality. Cognitive Behavioral Therapy (CBT) for delusio-
nality in patients who have an At Risk Mental State (ARMS) for 
a first psychosis yields promising results. Based on this research 
we have conducted a pilot study for treating delusionality (NEMO 
Group) in patients with Body Dysmorphic Disorder with CBT 
encompassing a training in recognizing and correcting cognitive 
biases including selective attention. The training was realized 
in an academic outpatient clinic. Results (n = 4) indicate that 
delusionality decreased, with respect to cognitive biases, and that 
quality of life improved. Moreover, we will present case series 
of 2 patients with delusional infestation (DI), who were treated 
at our psychodermatology outpatient clinic by a psychiatrist, 
psychologist and dermatologist with antipsychotics, CBT for 
delusionality like in our pilot group, regular dermatological eva-
luation and systemic interventions. Combined treatment resulted 
in a decrease of hallucinations, alcohol and benzodiazepines use, 
cleaning, compulsive rituals and self-injury and quality of life 
improved. In conclusion, we show new CBT interventions to treat 
delusionality and underline the importance of treating patients with 
DI in a multidisciplinary team.
